<p>/PRNewswire/ -- Premier Research，一家全球领先的临床研究和咨询服务公司，今天宣布任命 Siân Ratcliffe Smethurst 博士为首席运营官。</p>
<p>拥有超过 25 年生物制药行业的科学和运营领导经验，Ratcliffe Smethurst 博士将负责组织的临床研究和开发。在这个角色中，她将推动所有临床开发职能的运营和质量表现，包括研究设计和交付、数据管理和监管支持。</p>
<p>&#34;我很高兴欢迎 Siân 加入我们的执行团队，担任首席运营官，&#34; Premier 首席执行官 John Ratliff 说。&#34;这一战略任命支持 Premier 对高质量临床交付和运营可扩展性的承诺。我们相信 Siân 将推动我们的临床能力，改善现场和患者体验，并为我们的客户提升价值。&#34;</p>
<p>在加入 Premier 之前，Ratcliffe Smethurst 博士曾在 Biogen 和 Pfizer 担任多个高级领导职务，涵盖研究、开发和医学的所有阶段，以及多个治疗领域，包括肿瘤学、神经学、精神病学、疼痛、罕见疾病、免疫学、内科、女性健康和疫苗。最近，Ratcliffe Smethurst 博士在 Biogen 担任 SVP、定量科学与开发运营（QSDO）负责人，领导一个大型全球团队，负责 Biogen 临床试验组合的设计、战略规划、执行和分析。</p>
<p>&#34;我对能够为 Premier 的长期愿景做出贡献感到振奋，并期待与一支敬业且经验丰富的团队合作，&#34; Ratcliffe Smethurst 博士说。&#34;我们共同的承诺是将突破性的科学转化为改变生活的疗法，为患者带来真正的改变，同时为我们的利益相关者提供持久的价值。&#34;</p>
<p><strong>关于 Premier Research</strong> Premier Research International LLC（Premier）是一家全球领先的临床研究和咨询服务公司，专注于为生命科学行业提供高效有效的市场路径。Premier 以生物技术的需求为基础，通过解决试验复杂性、克服开发障碍和展示产品价值，将突破性的科学转化为改变生活的药物、设备和诊断。凭借深厚的治疗专业知识、创新技术和产品开发运营能力——从临床前规划到临床试验执行和商业化——我们的综合方法提供个性化的端到端解决方案，以识别做出明智决策所需的相关数据和洞察，并加快开发时间表，为更智能、更快速的批准路径提供支持。欲了解更多信息，请访问 premier-research.com。</p>
<p><strong>媒体联系人：</strong> Amber Frasketi</p>
<p>市场副总裁</p>
<p>[email protected]</p>
<p>+1 (919) 616-2431</p>
<p>来源 Premier Research International LLC</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTA2Jk5ld3NJdGVtSWQ9Q0w1NjUwOCZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMDYwNzU1UFJfTkVXU19VU1BSX19fX19DTDU2NTA4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTA2Jk5ld3NJdGVtSWQ9Q0w1NjUwOCZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMDYwNzU1UFJfTkVXU19VU1BSX19fX19DTDU2NTA4"/></p>

PINC

<p>Premier Research 任命 Siân Ratcliffe Smethurst 博士为首席运营官。她在生物制药行业拥有超过 25 年的经验，将负责临床研究和开发，提升运营绩效和质量。首席执行官 John Ratliff 对她改善临床能力和客户价值的能力表示信心。Ratcliffe Smethurst 博士曾在 Biogen 和 Pfizer 担任高级职务，专注于多个治疗领域。她旨在为 Premier 的愿景贡献力量，将科学转化为有影响力的疗法</p>

<p>, /PRNewswire/ -- Premier Research, a global leader in clinical research and consulting services, announced today the appointment of Siân Ratcliffe Smethurst, Ph.D., to the position of Chief Operating Officer.</p>
<div class="lb-trans"><p>/PRNewswire/ -- Premier Research，一家全球领先的临床研究和咨询服务公司，今天宣布任命 Siân Ratcliffe Smethurst 博士为首席运营官。</p>
</div><p>With more than 25 years of scientific and operational leadership in the biopharmaceutical industry, Dr. Ratcliffe Smethurst will oversee the organization's Clinical Research and Development. In this role, she will drive operational and quality performance across all clinical development functions, including study design and delivery, data management, and regulatory support.</p>
<div class="lb-trans"><p>拥有超过 25 年生物制药行业的科学和运营领导经验，Ratcliffe Smethurst 博士将负责组织的临床研究和开发。在这个角色中，她将推动所有临床开发职能的运营和质量表现，包括研究设计和交付、数据管理和监管支持。</p>
</div><p>&#34;I am pleased to welcome Siân to our executive team as Chief Operating Officer,&#34; said Premier Chief Executive Officer, John Ratliff. &#34;This strategic appointment supports Premier's commitment to high-quality clinical delivery and operational scalability. We are confident Siân will propel our clinical capabilities, improve the site and patient experience, and enhance value for our customers.&#34;</p>
<div class="lb-trans"><p>&#34;我很高兴欢迎 Siân 加入我们的执行团队，担任首席运营官，&#34; Premier 首席执行官 John Ratliff 说。&#34;这一战略任命支持 Premier 对高质量临床交付和运营可扩展性的承诺。我们相信 Siân 将推动我们的临床能力，改善现场和患者体验，并为我们的客户提升价值。&#34;</p>
</div><p>Prior to joining Premier, Dr. Ratcliffe Smethurst served in multiple senior leadership roles at Biogen and Pfizer spanning all phases of Research, Development, and Medical as well as multiple therapeutic areas, including Oncology, Neurology, Psychiatry, Pain, Rare Disease, Immunology, Internal Medicine, Women's Health, and Vaccines. Most recently, Dr. Ratcliffe Smethurst held the role of SVP, Head of Quantitative Sciences &amp; Development Operations (QSDO) at Biogen, where she led a large global team accountable for the design, strategic planning, execution, and analysis of Biogen's clinical trial portfolio.</p>
<div class="lb-trans"><p>在加入 Premier 之前，Ratcliffe Smethurst 博士曾在 Biogen 和 Pfizer 担任多个高级领导职务，涵盖研究、开发和医学的所有阶段，以及多个治疗领域，包括肿瘤学、神经学、精神病学、疼痛、罕见疾病、免疫学、内科、女性健康和疫苗。最近，Ratcliffe Smethurst 博士在 Biogen 担任 SVP、定量科学与开发运营（QSDO）负责人，领导一个大型全球团队，负责 Biogen 临床试验组合的设计、战略规划、执行和分析。</p>
</div><p>&#34;I am energized by the opportunity to contribute to Premier's long-term vision and look forward to collaborating with a committed and experienced team,&#34; said Dr. Ratcliffe Smethurst. &#34;Our shared commitment is to turn breakthrough science into life-changing therapies that make a real difference for patients, while delivering enduring value for our stakeholders.&#34;</p>
<div class="lb-trans"><p>&#34;我对能够为 Premier 的长期愿景做出贡献感到振奋，并期待与一支敬业且经验丰富的团队合作，&#34; Ratcliffe Smethurst 博士说。&#34;我们共同的承诺是将突破性的科学转化为改变生活的疗法，为患者带来真正的改变，同时为我们的利益相关者提供持久的价值。&#34;</p>
</div><p><strong>About Premier Research</strong> Premier Research International LLC (Premier) is a global leader in clinical research and consulting services with expertise in driving an efficient and effective path to market for the life sciences industry. Premier is built with the needs of biotech in mind, turning breakthrough science into life-changing drugs, devices, and diagnostics by addressing trial complexity, overcoming development hurdles, and demonstrating product value. Leveraging deep therapeutic expertise, innovative technology, and product development operational proficiency—from preclinical planning to clinical trial execution and commercialization—our integrated approach offers personalized, end-to-end solutions to identify the pertinent data and insight necessary to make informed decisions earlier and deliver accelerated development timelines for a smarter, faster path to approval. To learn more visit premier-research.com.</p>
<div class="lb-trans"><p><strong>关于 Premier Research</strong> Premier Research International LLC（Premier）是一家全球领先的临床研究和咨询服务公司，专注于为生命科学行业提供高效有效的市场路径。Premier 以生物技术的需求为基础，通过解决试验复杂性、克服开发障碍和展示产品价值，将突破性的科学转化为改变生活的药物、设备和诊断。凭借深厚的治疗专业知识、创新技术和产品开发运营能力——从临床前规划到临床试验执行和商业化——我们的综合方法提供个性化的端到端解决方案，以识别做出明智决策所需的相关数据和洞察，并加快开发时间表，为更智能、更快速的批准路径提供支持。欲了解更多信息，请访问 premier-research.com。</p>
</div><p><strong>Media Contact:</strong> Amber Frasketi</p>
<div class="lb-trans"><p><strong>媒体联系人：</strong> Amber Frasketi</p>
</div><p>Vice President, Marketing</p>
<div class="lb-trans"><p>市场副总裁</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>+1 (919) 616-2431</p>
<div class="lb-trans"><p>+1 (919) 616-2431</p>
</div><p>SOURCE Premier Research International LLC</p>
<div class="lb-trans"><p>来源 Premier Research International LLC</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTA2Jk5ld3NJdGVtSWQ9Q0w1NjUwOCZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMDYwNzU1UFJfTkVXU19VU1BSX19fX19DTDU2NTA4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=CL56508&amp;Transmission_Id=202601060755PR_NEWS_USPR_____CL56508&amp;DateId=20260106"/></p>

Siân Ratcliffe Smethurst 被任命为 Premier Research 的首席运营官